5-Y update of the randomized phase III trial DAHANCA19: Primary (Chemo) RT +/- zalutumumab in HNSCC

J. G. Eriksen, C. Maare, J. Johansen, H Primdahl, J. Evensen, C A Kristensen, Lisbeth Juhler Andersen, J Overgaard

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberOC-0271
JournalRadiotherapy & Oncology
Volume127
Issue numberSupplement 1
Pages (from-to)S137-S138
Number of pages2
ISSN0167-8140
DOIs
Publication statusPublished - 2018
Event37th Meeting of the European-Society-for-Radiotherapy-and-Oncology - Barcelona, Spain
Duration: 20 Apr 201824 Apr 2018

Conference

Conference37th Meeting of the European-Society-for-Radiotherapy-and-Oncology
CountrySpain
CityBarcelona
Period20/04/201824/04/2018

Cite this